Kanāda - angļu - Health Canada

pharmaris canada inc - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles

Kanāda - angļu - Health Canada

jamp pharma corporation - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles

Kanāda - angļu - Health Canada

auro pharma inc - voriconazole - powder - 200mg - voriconazole 200mg - azoles

Kanāda - angļu - Health Canada

fresenius kabi canada ltd - voriconazole - powder for solution - 200mg - voriconazole 200mg - azoles

Singapūra - angļu - HSA (Health Sciences Authority)

goldplus universal pte ltd - itraconazole - solution - itraconazole 10 mg/ml

Kanāda - angļu - Health Canada

jamp pharma corporation - voriconazole - tablet - 50mg - voriconazole 50mg

Kanāda - angļu - Health Canada

jamp pharma corporation - voriconazole - tablet - 200mg - voriconazole 200mg

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - voriconazole 200mg;  ;   - film coated tablet - 200 mg - active: voriconazole 200mg     excipient: croscarmellose sodium lactose monohydrate magnesium stearate opadry white oy-ls-28914 povidone pregelatinised maize starch purified water   - vfend is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida sp. infections (including c. krusei), including oesophageal and systemic candida sp. infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - voriconazole 50mg;  ;   - film coated tablet - 50 mg - active: voriconazole 50mg     excipient: croscarmellose sodium lactose monohydrate magnesium stearate opadry white oy-ls-28914 povidone pregelatinised maize starch purified water   - vfend is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida sp. infections (including c. krusei), including oesophageal and systemic candida sp. infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - voriconazole 200mg;  ;   - powder for injection - 200 mg - active: voriconazole 200mg     excipient: sulfobutyl betadex sodium water for injection - vfend is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida sp. infections (including c. krusei), including oesophageal and systemic candida sp. infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.